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LETTER TO THE EDITOR
New Delhi metallo-b-lactamase and OXA-48
carbapenemases in Gram-negative bacilli isolates
in Libya
To the Editor
Carbapenems (i.e. ertapenem, imipenem, meropenem,
and doripenem) are second line antimicrobials reserved
to treat serious infections, including those caused by Gram-
negative bacilli (GNB) producing extended-spectrum
b-lactamses (ESBLs). ESBLs mediate resistance among
GNB to b-lactam drugs, including third generation
cephalosporins. Emergence of carbapenemases-producing
GNB (mainly Acinetobacter baumanii, Pseudomonas
aeruginosa, and members of the family Enterobacteria-
ceae) in the last decade is a serious health problem
globally. Carbapenemases are members of three molecu-
lar groups of b-lactamases, Ambler class A, B (i.e.
metallo b-lactamases [MBLs]), and D (i.e. oxacillinases)
(1, 2). Recently, the novel carbapenemase New Delhi
MBL (NDM) was reported for the first time in Tunisia in
Klebsiella pneumoniae isolated from a female patient
transferred from Libya (3). However, there is little
information regarding genes associated with carbapenem
resistance among GNB in Libya.
Included in the study were eight GNB isolates that are
resistant to at least one carbapenem (i.e. ertapenem)
obtained in 2013 and 2014 from different clinical speci-
mens from patients at the time an infection occurred.
Patients were aged between 10 and 87 years (mean37.1
years). Information about patients and the organisms
isolated from them included in the study are shown in
Table 1. In this prospective investigation, clinical speci-
mens were collected under approved ethical standards,
and the study was reviewed and approved by the
Academy of Graduate Studies, Tripoli, Libya.
All specimens were cultured on plates of blood agar and
MacConkey agar (Oxoid Ltd., Basingstoke, Hampshire,
UK) and incubated at 378C for 2448 h. Isolated orga-
nisms were identified to the species level and tested for their
susceptibility to avariety of antimicrobial agents by the BD
Phoenix Automated Microbiology System (PAMS, MSBD
Biosciences, Sparks, MD, USA) as recommended by the
manufacturer. PAMS provides antimicrobial susceptibility
results as susceptible (S), intermediate susceptible (I), or
resistant (R) and are interpreted according to Clinical and
Laboratory Standards Institute criteria (4). Quality con-
trol strains used included Escherichia coli ATCC 25922,
K. pneumoniae ATCC 700603, and P. aeruginosa ATCC
27853 (ATCC, LGC Standards S.r.l., Italy). Furthermore,
six of the GNB isolates were tested phenotypically for the
production of MBLs by the MIC Test Strip MBL
(Liofilchem, Rosetodegli Abruzzi, Italy) as recommended
by the manufacturer.
All eight isolateswere examined forgenes encoding ESBLs
blaCTX-M, blaGES, blaVEB, blaPER, or blaBES and carbape-
nemases blaKPC, blaVIM, blaNDM, or blaOXA-48 by poly-
merase chain reaction (PCR) using primers and conditions
described previously (5, 6). In addition, both A. baumanii
isolates were further tested for carbapenemase genes
blaOXA-23-like, blaOXA-24/40-like, blaOXA-143-like, blaOXA-51-like,
and blaOXA-58-like using PCR as above.
All A. baumanii and Pseudomonas sp. isolates were
resistant to the three carbapenems as well as to nearly all
other antimicrobials that were used. Only colisitin showed
excellent activity against the GNB isolates investigated
(100% susceptible) followed by amikacin (50% susceptible).
Furthermore, all organisms were multidrug resistant
(MDR; resistance to three or more antimicrobial groups).
Table 2 shows the antimicrobial susceptibility of the
investigated GNB isolates.
Of the ESBLs genes examined, blaCTX-M was detected in
one K. pneumoniae and in the Enterobacter gergoviae
isolate, and blaGES in the P. aeruginosa isolate. Other
ESBL genes examined were not detected in all eight GNB
isolates. Of the carbapenemase genes investigated, blaNDM
was detected in one K. pneumoniae, and blaOXA-48 in
E. gergoviae and in another K. pneumoniae isolate. On
the other hand, the carbapenemase gene blaKPC was not
detected in all isolates investigated. Table 3 shows genes
encoding ESBLs and carbapenemases in the GNB isolates
from Tripoli, Libya.
Oxacillinases are mainly present in Acinetobacter sp. (7),
and some of them are intrinsic to the organism (e.g. OXA-
51) while others are acquired (e.g. OXA-23). blaOXA-23-like
and blaOXA-51-like were found in both A. baumanii isolates.
Recently, Mathlouthi et al. (8) reported MDR A. bau-
mannii isolates harboring blaOXA-23-like, blaOXA-24-like, and
blaOXA-48-like genes in Libya.
On the other hand, we identified OXA-48 in one K.
pneumoniae as well as in the E. gergoviae isolate. Kocsis
et al. (9) reported K. pneumoniae harboring OXA-48
carbapenemase in a Libyan refugee in Italy. In addi-
tion, several studies reported OXA-48 carbapenemase-
producing K. pneumoniae in patients transferred from
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Table 2. Antimicrobial susceptibility and metallo-b-lactamases of Gram-negative bacilli isolates from different clinical
specimens in Tripoli, Libya
Antimicrobial agent
No. Organism AM CN EP IP MP CX CR CT CZ CP AN PT TS CF LF CL MBLs
1 Acinetobacter baumannii R R R R R R R R R R R R R R R S 
2 Acinetobacter baumannii R R R R R R R R R R R R S R R S ND
3 Pseudomonas aeruginosa R R R R R R R R I I I S R R R S 
4 Pseudomonas putida R R R R R R R R R R R R R S S S 
5 Escherichia coli S R R S S R R R S R R S R R R S 
6 Klebsiella pneumoniae S S R R R R R R R R R R R R R S 
7 Klebsiella pneumoniae S R R I R R R R R R R R S R R S 
8 Enterobacter gergoviae S R R S R R R R R R R R S R R S ND
AKamikacin, CNgentamicin, EPertapenem, IPimipenem, MPmeropenem, CXcefoxitin, CRcefuroxime, CTceftriaxone,
CZceftazidime, CPcefepime, ANaztronam, PTpipracillin-tazobactam, TStrimethoprim-sulfamethoxazole, CFciprofloxacin,
LFlevofloxacin, CLcolisitin. Ssusceptible, Iintermediate susceptible, Rresistant, MTLsmetallo b-lactamases tested
phenotypically,  positive, negative, NDnot done.
Table 3. Genes encoding extended-spectrum b-lactamases (ESBLs) and carbapenemases in Gram-negative bacilli from Tripoli,
Libya
ESBLs genesa Carbapenemase genesa,b
No. Organism blaCTX-M blaGES blaNDM blaVIM blaOXA-48 blaOXA-23-like blaOXA-51-like
1 Acinetobacter baumannii N N N N N P P
2 Acinetobacter baumannii N N N N N P P
3 Pseudomonas aeruginosa N P N N N ND ND
4 Pseudomonas putida N N N P N ND ND
5 Escherichia coli N N N N N ND ND
6 Klebsiella pneumoniae P N P N N ND ND
7 Klebsiella pneumoniae N N N N P ND ND
8 Enterobacter gergoviae P N N N P ND ND
aESBLs genes blaVEB, blaPER and blaBES and carbapenemase gene blaKPC were not detected in all eight isolates tested.
bCarbapenemases genes blaOXA-24/40-like, blaOXA-58-like and blaOXA-143 were not detected in both A. baumanii isolates examined.
Nnegative, Ppositive, NDnot done.
Table 1. Information about patients and their isolated organisms
Patient Gender Age (years) Hospital/department Hospital admission Specimen Organism isolated
1 Male 30 TMC/ICU Inpatient Endotracheal tube tip Acinetobacter baumannii
2 Female 57 TMC/GSICU Inpatient Suction tip Acinetobacter baumannii
3 Female 46 TMC/ICU Inpatient Sputum Pseudomonas aeruginosa
4 Male 25 BPSH/ICU Inpatient Wound swab Pseudomonas putida
5 Male 10 BPSH Outpatient Wound swab Escherichia coli
6 Male 87 TMC Outpatient Ear swab Klebsiella pneumoniae
7 Female 42 TMC/Endo Inpatient Bedsore swab Klebsiella pneumoniae
8 Male 30 TMC/GSICU Inpatient Wound swab Enterobacter gergoviae
TMCTripoli Medical Center, BPSHBurn and Pediatric Surgery Hospital, ICUintensive care unit, GSICUgeneral surgical ICU,
OPoutpatient, Endoendocrinology.
TMC and BPSH are both located in Tripoli.
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Libya to neighboring and European countries (e.g. Tunisia,
Denmark, and Slovenia) (3, 1012). However, there
are no reports of blaOXA-48-positive K. pneumonia and
E. gergoviae from Libya.
Both blaCTX-M and blaNDM were detected in Klebsiella
pneumoniae isolated from an ear swab from a female
outpatient with an ear infection. This isolate was also
positive for MBLs by the phenotypic method used
(Table 2). K. pneumoniae harboring blaNDM has not been
reported from Libya in the past.
Genes coding for the ESBLs and carbapenemases
tested were not detected in the E. coli isolate. However,
the organism was ESBL-positive phenotypically (data
not shown), which may suggest that other ESBLs not
investigated in this work might be responsible for its
resistance to the third generation cephalosporin.
In conclusion, to the authors’ knowledge this is
the first report from Libya of K. pneumoniae harbor-
ing blaNDM and blaCTX-M, K. pneumoniae harboring
blaOXA-48, and E. gergoviae harboring blaOXA-48 and
blaCTX-M. Emergence of MDR GNB harboring genes
coding for carbapenemases will undoubtedly limit the use
of carbapenems in treating serious infectious in the
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